How does methyldopa affect cardiac output in patients with systolic hypertension and what are the implications for cardiac performance?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa reduces cardiac output by decreasing heart rate and contractility, which might worsen cardiac performance in patients with systolic hypertension.